🧬 TP53

Tumor suppressor gene - most commonly mutated in human cancers

🧬 KRAS

Oncogene frequently mutated in pancreatic, colorectal, and lung cancers

🧬 EGFR

Receptor tyrosine kinase - target for lung cancer therapy

🧬 HER2

Growth factor receptor overexpressed in breast and gastric cancers

🧬 BRCA1

Hereditary breast and ovarian cancer gene

🧬 BRCA2

Hereditary breast and ovarian cancer gene

🧬 PD-L1

Immune checkpoint protein - predictor for immunotherapy response

🧬 ALK

Fusion gene target in non-small cell lung cancer

🧬 ROS1

Receptor tyrosine kinase fusion in lung cancer

🧬 BRAF

Oncogene mutated in melanoma and colorectal cancer

🧬 MSI-H

DNA mismatch repair deficiency - immunotherapy biomarker

🧬 PIK3CA

Oncogene frequently mutated in breast cancer

🧬 NTRK

Fusion gene target across multiple tumor types

🧬 MET

Receptor tyrosine kinase target in lung cancer

🧬 RET

Fusion gene target in thyroid and lung cancers

🧬 Liquid Biopsies

Blood-based cancer detection and monitoring methods

🧬 ctDNA Testing

Circulating tumor DNA analysis for cancer detection

🧬 Tumor Mutation Burden

Genomic biomarker predicting immunotherapy response